Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$622,265,747
+$134,843,861 QoQ
Shares Held
5,604,483
0.0% QoQ
Ownership
8.14%
of shares outstanding
% of Portfolio
3.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. RYTM ranks #10 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,762,330 | $3,487,217,728 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,801,567 | $2,508,182,547 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
11,443,357 | $2,143,111,898 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,143,131 | $1,150,754,190 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,912,904 | $1,085,696,471 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
8,657,242 | $992,725,940 | |
| 7 | INSM |
INSMED Inc
|
8,796,111 | $937,841,354 | |
| 8 | CELC |
Celcuity Inc.
|
7,915,792 | $828,150,159 |
All Filings in RYTM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $622,265,747 | 5,604,483 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $487,421,886 | 5,604,483 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $599,903,860 | 5,604,483 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $565,996,738 | 5,604,483 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $354,147,280 | 5,604,483 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $296,869,464 | 5,604,483 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $340,596,259 | 6,084,249 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $335,210,394 | 6,398,366 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $262,716,866 | 6,398,365 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $277,241,155 | 6,398,365 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $294,132,839 | 6,398,365 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $153,651,350 | 6,702,349 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $107,156,422 | 6,498,267 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $115,929,083 | 6,498,267 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $185,046,184 | 6,354,608 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $148,536,199 | 6,062,702 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $17,119,007 | 4,125,062 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $47,520,714 | 4,125,062 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $38,555,125 | 3,863,239 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $50,453,901 | 3,863,239 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $75,642,219 | 3,863,239 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $74,016,898 | 3,479,873 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $68,821,174 | 2,314,873 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $53,549,928 | 2,471,155 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $60,211,226 | 2,700,055 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $41,218,804 | 2,708,200 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||